Clinical Trials Directory

Trials / Completed

CompletedNCT01162174

Pilot Study of Oligonol Supplementation to Promote Cardiovascular Health

Effects of Oligonol on Vascular Function and Inflammation in Healthy Men: A Double-Blind, Dose-Finding Study

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
16 (actual)
Sponsor
University of California, Davis · Academic / Other
Sex
Male
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The investigators hypothesize that acute consumption of Oligonol, a patented lychee fruit extract (Amino Up Chemical Co.) particularly rich in low molecular weight flavanols, will improve endothelial function, reduce platelet reactivity and increase circulating levels of flavonoids after a single intake.

Detailed description

The investigators have demonstrated from previous studies at UC Davis that a single dose of a high-flavanol supplement from cocoa can improve endothelial function, measured by increased blood flow from peripheral arterial tonometry (PAT), reduce platelet reactivity, and increase circulating levels of flavonoids in the blood. The investigators seek with this proposal to determine if a similar response can be noted with a different high-flavanol supplement in normal, healthy people.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTOligonol

Timeline

Start date
2008-08-01
Primary completion
2009-02-01
Completion
2009-02-01
First posted
2010-07-14
Last updated
2010-07-14

Source: ClinicalTrials.gov record NCT01162174. Inclusion in this directory is not an endorsement.